ID SNED1_HUMAN Reviewed; 1413 AA. AC Q8TER0; B5MDC3; B7WNK6; B7WPM0; Q336F4; Q336F5; Q8N369; Q8TEP7; DT 11-SEP-2007, integrated into UniProtKB/Swiss-Prot. DT 11-SEP-2007, sequence version 2. DT 27-MAR-2024, entry version 162. DE RecName: Full=Sushi, nidogen and EGF-like domain-containing protein 1 {ECO:0000305}; DE AltName: Full=Insulin-responsive sequence DNA-binding protein 1 {ECO:0000303|PubMed:15194686}; DE Short=IRE-BP1 {ECO:0000303|PubMed:15194686}; DE Flags: Precursor; GN Name=SNED1 {ECO:0000303|PubMed:33724335, ECO:0000312|HGNC:HGNC:24696}; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15815621; DOI=10.1038/nature03466; RA Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P., RA Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C., RA Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L., RA Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A., RA Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J., RA Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M., RA Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T., RA Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S., RA Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K., RA McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C., RA Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S., RA Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C., RA Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M., RA Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C., RA Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J., RA Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E., RA Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X., RA Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M., RA Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C., RA Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S., RA Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H., RA Wilson R.K.; RT "Generation and annotation of the DNA sequences of human chromosomes 2 and RT 4."; RL Nature 434:724-731(2005). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 132-1413 (ISOFORM 1), AND RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 831-1413 (ISOFORM 2). RC TISSUE=Spleen; RA Jikuya H., Takano J., Nomura N., Kikuno R., Nagase T., Ohara O.; RT "The nucleotide sequence of a long cDNA clone isolated from human spleen."; RL Submitted (JAN-2002) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [MRNA] OF 367-1413 (ISOFORM 1), AND NUCLEOTIDE SEQUENCE RP [MRNA] OF 938-1413 (ISOFORM 4). RX PubMed=15194686; DOI=10.1074/jbc.m404349200; RA Villafuerte B.C., Phillips L.S., Rane M.J., Zhao W.; RT "Insulin-response element-binding protein 1: a novel Akt substrate involved RT in transcriptional action of insulin."; RL J. Biol. Chem. 279:36650-36659(2004). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 791-1413 (ISOFORM 3), AND VARIANT RP SER-1362. RC TISSUE=Lung; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [5] RP SUBCELLULAR LOCATION, GLYCOSYLATION, AND PHOSPHORYLATION. RX PubMed=33724335; DOI=10.1042/bcj20200675; RA Vallet S.D., Davis M.N., Barque A., Thahab A.H., Ricard-Blum S., Naba A.; RT "Computational and experimental characterization of the novel ECM RT glycoprotein SNED1 and prediction of its interactome."; RL Biochem. J. 478:1413-1434(2021). CC -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular CC matrix {ECO:0000269|PubMed:33724335}. Note=Forms microfibrils within CC the extracellular matrix and colocalizes with fibronectin (FN1). CC {ECO:0000250|UniProtKB:Q70E20}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=4; CC Name=1; CC IsoId=Q8TER0-1; Sequence=Displayed; CC Name=2; CC IsoId=Q8TER0-3; Sequence=VSP_027749, VSP_027752; CC Name=3; CC IsoId=Q8TER0-4; Sequence=VSP_027749, VSP_027753, VSP_027754; CC Name=4; CC IsoId=Q8TER0-5; Sequence=VSP_027750, VSP_027751; CC -!- PTM: Phosphorylated on serine and threonine residues. CC {ECO:0000269|PubMed:33724335}. CC -!- PTM: N-glycosylated. {ECO:0000269|PubMed:33724335}. CC -!- SEQUENCE CAUTION: CC Sequence=AAH27939.1; Type=Miscellaneous discrepancy; Note=Intron retention. The N-terminal region arises from intron retention.; Evidence={ECO:0000305}; CC Sequence=AAQ04558.1; Type=Erroneous initiation; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AC005237; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AC093585; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AC104809; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AK074062; BAB84888.1; -; mRNA. DR EMBL; AK074075; BAB84901.1; -; mRNA. DR EMBL; AF439717; AAQ04558.1; ALT_INIT; mRNA. DR EMBL; AF439718; AAQ04563.1; -; mRNA. DR EMBL; BC027939; AAH27939.1; ALT_SEQ; mRNA. DR CCDS; CCDS46562.1; -. [Q8TER0-1] DR RefSeq; NP_001073906.1; NM_001080437.1. [Q8TER0-1] DR AlphaFoldDB; Q8TER0; -. DR SMR; Q8TER0; -. DR BioGRID; 117471; 4. DR IntAct; Q8TER0; 1. DR STRING; 9606.ENSP00000308893; -. DR GlyCosmos; Q8TER0; 15 sites, 1 glycan. DR GlyGen; Q8TER0; 17 sites, 2 O-linked glycans (3 sites). DR iPTMnet; Q8TER0; -. DR PhosphoSitePlus; Q8TER0; -. DR BioMuta; SNED1; -. DR DMDM; 158563933; -. DR EPD; Q8TER0; -. DR jPOST; Q8TER0; -. DR MassIVE; Q8TER0; -. DR PaxDb; 9606-ENSP00000308893; -. DR PeptideAtlas; Q8TER0; -. DR ProteomicsDB; 74481; -. [Q8TER0-1] DR ProteomicsDB; 74482; -. [Q8TER0-3] DR ProteomicsDB; 74483; -. [Q8TER0-4] DR ProteomicsDB; 74484; -. [Q8TER0-5] DR Antibodypedia; 34540; 82 antibodies from 16 providers. DR DNASU; 25992; -. DR Ensembl; ENST00000310397.13; ENSP00000308893.8; ENSG00000162804.15. [Q8TER0-1] DR Ensembl; ENST00000401884.5; ENSP00000384871.1; ENSG00000162804.15. [Q8TER0-5] DR Ensembl; ENST00000405547.7; ENSP00000386007.3; ENSG00000162804.15. [Q8TER0-3] DR GeneID; 25992; -. DR KEGG; hsa:25992; -. DR MANE-Select; ENST00000310397.13; ENSP00000308893.8; NM_001080437.3; NP_001073906.1. DR UCSC; uc002wah.2; human. [Q8TER0-1] DR AGR; HGNC:24696; -. DR CTD; 25992; -. DR DisGeNET; 25992; -. DR GeneCards; SNED1; -. DR HGNC; HGNC:24696; SNED1. DR HPA; ENSG00000162804; Low tissue specificity. DR MIM; 616634; gene. DR neXtProt; NX_Q8TER0; -. DR OpenTargets; ENSG00000162804; -. DR PharmGKB; PA134946370; -. DR VEuPathDB; HostDB:ENSG00000162804; -. DR eggNOG; KOG1217; Eukaryota. DR eggNOG; KOG4291; Eukaryota. DR GeneTree; ENSGT00940000160730; -. DR HOGENOM; CLU_005107_0_0_1; -. DR InParanoid; Q8TER0; -. DR OMA; KAIRHRT; -. DR OrthoDB; 5475408at2759; -. DR PhylomeDB; Q8TER0; -. DR TreeFam; TF335195; -. DR PathwayCommons; Q8TER0; -. DR SignaLink; Q8TER0; -. DR BioGRID-ORCS; 25992; 8 hits in 1137 CRISPR screens. DR ChiTaRS; SNED1; human. DR GenomeRNAi; 25992; -. DR Pharos; Q8TER0; Tbio. DR PRO; PR:Q8TER0; -. DR Proteomes; UP000005640; Chromosome 2. DR RNAct; Q8TER0; Protein. DR Bgee; ENSG00000162804; Expressed in sural nerve and 158 other cell types or tissues. DR ExpressionAtlas; Q8TER0; baseline and differential. DR GO; GO:0031012; C:extracellular matrix; IDA:UniProtKB. DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-KW. DR GO; GO:0005509; F:calcium ion binding; IEA:InterPro. DR GO; GO:0005112; F:Notch binding; IBA:GO_Central. DR GO; GO:0007160; P:cell-matrix adhesion; IEA:InterPro. DR CDD; cd00033; CCP; 1. DR CDD; cd00054; EGF_CA; 12. DR CDD; cd00063; FN3; 3. DR Gene3D; 2.60.40.10; Immunoglobulins; 3. DR Gene3D; 2.10.25.10; Laminin; 15. DR InterPro; IPR001881; EGF-like_Ca-bd_dom. DR InterPro; IPR013032; EGF-like_CS. DR InterPro; IPR000742; EGF-like_dom. DR InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site. DR InterPro; IPR018097; EGF_Ca-bd_CS. DR InterPro; IPR003961; FN3_dom. DR InterPro; IPR036116; FN3_sf. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR003886; NIDO_dom. DR InterPro; IPR035976; Sushi/SCR/CCP_sf. DR InterPro; IPR000436; Sushi_SCR_CCP_dom. DR PANTHER; PTHR24044; NOTCH LIGAND FAMILY MEMBER; 1. DR Pfam; PF00008; EGF; 11. DR Pfam; PF00041; fn3; 3. DR Pfam; PF12661; hEGF; 3. DR Pfam; PF06119; NIDO; 1. DR PRINTS; PR00010; EGFBLOOD. DR SMART; SM00032; CCP; 1. DR SMART; SM00181; EGF; 15. DR SMART; SM00179; EGF_CA; 14. DR SMART; SM00060; FN3; 3. DR SMART; SM00539; NIDO; 1. DR SUPFAM; SSF57535; Complement control module/SCR domain; 1. DR SUPFAM; SSF57196; EGF/Laminin; 15. DR SUPFAM; SSF49265; Fibronectin type III; 2. DR PROSITE; PS00010; ASX_HYDROXYL; 5. DR PROSITE; PS00022; EGF_1; 15. DR PROSITE; PS01186; EGF_2; 13. DR PROSITE; PS50026; EGF_3; 15. DR PROSITE; PS01187; EGF_CA; 3. DR PROSITE; PS50853; FN3; 3. DR PROSITE; PS51220; NIDO; 1. DR PROSITE; PS50923; SUSHI; 1. DR Genevisible; Q8TER0; HS. PE 1: Evidence at protein level; KW Alternative splicing; Calcium; Disulfide bond; EGF-like domain; KW Extracellular matrix; Glycoprotein; Phosphoprotein; Reference proteome; KW Repeat; Secreted; Signal; Sushi. FT SIGNAL 1..24 FT /evidence="ECO:0000255" FT CHAIN 25..1413 FT /note="Sushi, nidogen and EGF-like domain-containing FT protein 1" FT /id="PRO_0000299554" FT DOMAIN 103..258 FT /note="NIDO" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00570" FT DOMAIN 268..309 FT /note="EGF-like 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DOMAIN 311..347 FT /note="EGF-like 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DOMAIN 349..385 FT /note="EGF-like 3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DOMAIN 352..374 FT /note="Follistatin-like 1" FT DOMAIN 387..423 FT /note="EGF-like 4; calcium-binding" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DOMAIN 429..465 FT /note="EGF-like 5" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DOMAIN 468..500 FT /note="EGF-like 6" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DOMAIN 507..530 FT /note="Follistatin-like 2" FT DOMAIN 541..577 FT /note="EGF-like 7" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DOMAIN 580..616 FT /note="EGF-like 8" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DOMAIN 619..655 FT /note="EGF-like 9" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DOMAIN 657..693 FT /note="EGF-like 10" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DOMAIN 696..753 FT /note="Sushi" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00302" FT DOMAIN 753..789 FT /note="EGF-like 11; calcium-binding" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DOMAIN 791..827 FT /note="EGF-like 12; calcium-binding" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DOMAIN 829..865 FT /note="EGF-like 13" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DOMAIN 867..903 FT /note="EGF-like 14" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DOMAIN 908..1006 FT /note="Fibronectin type-III 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00316" FT DOMAIN 1007..1105 FT /note="Fibronectin type-III 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00316" FT DOMAIN 1106..1200 FT /note="Fibronectin type-III 3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00316" FT DOMAIN 1307..1343 FT /note="EGF-like 15" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT REGION 1206..1226 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1394..1413 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT CARBOHYD 145 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 204 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 292 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 368 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 408 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 484 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 536 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 712 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 886 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 977 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1015 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1109 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1139 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1310 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 272..284 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 278..297 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 299..308 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 315..326 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 320..335 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 337..346 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 353..364 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 358..373 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 375..384 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 391..402 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 396..411 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 413..422 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 433..444 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 438..453 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 455..464 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 472..480 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 474..488 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 490..499 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 545..556 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 550..565 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 567..576 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 584..595 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 589..604 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 606..615 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 623..634 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 628..643 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 645..654 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 661..672 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 666..681 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 683..692 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 698..739 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00302" FT DISULFID 724..751 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00302" FT DISULFID 757..768 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 762..777 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 779..788 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 795..806 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 800..815 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 817..826 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 833..844 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 838..853 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 855..864 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 871..882 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 876..891 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 893..902 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 1311..1322 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 1316..1331 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DISULFID 1333..1342 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT VAR_SEQ 1273..1306 FT /note="QPTASAQLENMEEAPKRVSLALQLPEHGSKDIGN -> H (in isoform FT 2 and isoform 3)" FT /evidence="ECO:0000303|PubMed:15489334, ECO:0000303|Ref.2" FT /id="VSP_027749" FT VAR_SEQ 1306..1324 FT /note="NVPGNCSENPCQNGGTCVP -> SESAALVGTLGLTDCSQGP (in FT isoform 4)" FT /evidence="ECO:0000303|PubMed:15194686" FT /id="VSP_027750" FT VAR_SEQ 1325..1413 FT /note="Missing (in isoform 4)" FT /evidence="ECO:0000303|PubMed:15194686" FT /id="VSP_027751" FT VAR_SEQ 1375..1402 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000303|Ref.2" FT /id="VSP_027752" FT VAR_SEQ 1398 FT /note="K -> L (in isoform 3)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_027753" FT VAR_SEQ 1399..1413 FT /note="Missing (in isoform 3)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_027754" FT VARIANT 1228 FT /note="L -> P (in dbSNP:rs17440466)" FT /id="VAR_034847" FT VARIANT 1289 FT /note="R -> Q (in dbSNP:rs6721345)" FT /id="VAR_034848" FT VARIANT 1299 FT /note="H -> R (in dbSNP:rs6708120)" FT /id="VAR_034849" FT VARIANT 1362 FT /note="A -> S (in dbSNP:rs2108485)" FT /evidence="ECO:0000269|PubMed:15489334" FT /id="VAR_034850" FT CONFLICT 546 FT /note="D -> N (in Ref. 3; AAQ04558)" FT /evidence="ECO:0000305" FT CONFLICT 653 FT /note="H -> Y (in Ref. 3; AAQ04558)" FT /evidence="ECO:0000305" FT CONFLICT 719 FT /note="V -> A (in Ref. 3; AAQ04558)" FT /evidence="ECO:0000305" FT CONFLICT 858 FT /note="S -> G (in Ref. 3; AAQ04558)" FT /evidence="ECO:0000305" FT CONFLICT 1186..1206 FT /note="HSEPAHLYIITSPRDGADRRW -> Q (in Ref. 3; AAQ04558)" FT /evidence="ECO:0000305" SQ SEQUENCE 1413 AA; 152204 MW; 09BC8059234326D9 CRC64; MRHGVAWALL VAAALGLGAR GVRGAVALAD FYPFGAERGD AVTPKQDDGG SGLRPLSVPF PFFGAEHSGL YVNNNGIISF LKEVSQFTPV AFPIAKDRCV VAAFWADVDN RRAGDVYYRE ATDPAMLRRA TEDVRHYFPE LLDFNATWVF VATWYRVTFF GGSSSSPVNT FQTVLITDGK LSFTIFNYES IVWTTGTHAS SGGNATGLGG IAAQAGFNAG DGQRYFSIPG SRTADMAEVE TTTNVGVPGR WAFRIDDAQV RVGGCGHTTS VCLALRPCLN GGKCIDDCVT GNPSYTCSCL SGFTGRRCHL DVNECASQPC QNGGTCTHGI NSFRCQCPAG FGGPTCETAQ SPCDTKECQH GGQCQVENGS AVCVCQAGYT GAACEMDVDD CSPDPCLNGG SCVDLVGNYT CLCAEPFKGL RCETGDHPVP DACLSAPCHN GGTCVDADQG YVCECPEGFM GLDCRERVPD DCECRNGGRC LGANTTLCQC PLGFFGLLCE FEITAMPCNM NTQCPDGGYC MEHGGSYLCV CHTDHNASHS LPSPCDSDPC FNGGSCDAHD DSYTCECPRG FHGKHCEKAR PHLCSSGPCR NGGTCKEAGG EYHCSCPYRF TGRHCEIGKP DSCASGPCHN GGTCFHYIGK YKCDCPPGFS GRHCEIAPSP CFRSPCVNGG TCEDRDTDFF CHCQAGYMGR RCQAEVDCGP PEEVKHATLR FNGTRLGAVA LYACDRGYSL SAPSRIRVCQ PHGVWSEPPQ CLEIDECRSQ PCLHGGSCQD RVAGYLCLCS TGYEGAHCEL ERDECRAHPC RNGGSCRNLP GAYVCRCPAG FVGVHCETEV DACDSSPCQH GGRCESGGGA YLCVCPESFF GYHCETVSDP CFSSPCGGRG YCLASNGSHS CTCKVGYTGE DCAKELFPPT ALKMERVEES GVSISWNPPN GPAARQMLDG YAVTYVSSDG SYRRTDFVDR TRSSHQLQAL AAGRAYNISV FSVKRNSNNK NDISRPAVLL ARTRPRPVEG FEVTNVTAST ISVQWALHRI RHATVSGVRV SIRHPEALRD QATDVDRSVD RFTFRALLPG KRYTIQLTTL SGLRGEEHPT ESLATAPTHV WTRPLPPANL TAARVTATSA HVVWDAPTPG SLLEAYVINV TTSQSTKSRY VPNGKLASYT VRDLLPGRRY QLSVIAVQST ELGPQHSEPA HLYIITSPRD GADRRWHQGG HHPRVLKNRP PPARLPELRL LNDHSAPETP TQPPRFSELV DGRGRVSARF GGSPSKAATV RSQPTASAQL ENMEEAPKRV SLALQLPEHG SKDIGNVPGN CSENPCQNGG TCVPGADAHS CDCGPGFKGR RCELACIKVS RPCTRLFSET KAFPVWEGGV CHHVYKRVYR VHQDICFKES CESTSLKKTP NRKQSKSQTL EKS //